查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317947

人类生长激素市场：途径、类型、分布和用途- 2023-2030 年全球预测

Human Growth Hormone Market by Route of Administration, Type, Distribution, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球人类生长激素市场规模将达57.7493亿美元，复合年复合成长率为8.85%，预计2030年将达到104.691亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球人类生长激素市场至关重要。透过检视业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使用户能够根据自己的具体需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球人类生长激素市场规模及预测为何？

2.在预测期内，COVID-19对全球人类生长激素市场的阻碍因素与影响有哪些？

3. 在预测期内，全球人类生长激素市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球人类生长激素市场的竞争策略是什么？

5. 全球人类生长激素市场的技术趋势和法律规范是什么？

6.全球人类生长激素市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入全球人类生长激素市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 与荷尔蒙失调有关的病例正在迅速增加
      • 增加赎回政策
      • 生长激素缺乏症增加
    • 抑制因素
      • 与人类生长激素治疗程序相关的费用很高
    • 机会
      • 人类生长激素产品上市数量增加
      • 不仅来自公部门而且来自私部门的研发资金也在迅速增加。
    • 任务
      • 人类生长激素治疗对人体的不良影响
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章人类生长激素市场：依给药途径

  • 肌肉注射
  • 静脉
  • 口服
  • 皮下的

第7章人类生长激素市场：依类型

  • 胺基酸衍生物
  • 胜肽激素
  • 类固醇激素

第8章人类生长激素市场分布

  • 医院药房
  • 网路药房
  • 零售药房

第9章人类生长激素市场：依用途

  • 生长激素缺乏症
  • 普瑞德威利症候群
  • 特纳氏症候群

第10章美洲人类生长激素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太人类生长激素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲人类生长激素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-43127F7278D5

The Global Human Growth Hormone Market is forecasted to grow significantly, with a projected USD 5,774.93 million in 2023 at a CAGR of 8.85% and expected to reach a staggering USD 10,469.10 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Growth Hormone Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Growth Hormone Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Route of Administration, market is studied across Intramuscular, Intravenous, Oral, and Subcutaneous. The Oral is projected to witness significant market share during forecast period.

Based on Type, market is studied across Amino Acid Derivatives, Peptide Hormones, and Steroid Hormones. The Amino Acid Derivatives is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.

Based on Application, market is studied across Growth Hormone Deficiency, Prader-Willi Syndrome, and Turner Syndrome. The Turner Syndrome is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Growth Hormone Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Growth Hormone Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Growth Hormone Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Growth Hormone Market?

4. What is the competitive strategic window for opportunities in the Global Human Growth Hormone Market?

5. What are the technology trends and regulatory frameworks in the Global Human Growth Hormone Market?

6. What is the market share of the leading vendors in the Global Human Growth Hormone Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Growth Hormone Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Human Growth Hormone Market, by Route of Administration, 2022 vs 2030
  • 4.3. Human Growth Hormone Market, by Type, 2022 vs 2030
  • 4.4. Human Growth Hormone Market, by Distribution, 2022 vs 2030
  • 4.5. Human Growth Hormone Market, by Application, 2022 vs 2030
  • 4.6. Human Growth Hormone Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the cases related to the hormonal disorders
      • 5.1.1.2. Increase in the reimbursement policies
      • 5.1.1.3. Growing growth hormone deficiency disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Cost related to human growth hormone therapies procedures is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing number of product launches of the human growth hormone
      • 5.1.3.2. Surge in research and development fundings from the private as well as public sector
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impact of human growth hormone therapies on human bodies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Human Growth Hormone Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intramuscular
  • 6.3. Intravenous
  • 6.4. Oral
  • 6.5. Subcutaneous

7. Human Growth Hormone Market, by Type

  • 7.1. Introduction
  • 7.2. Amino Acid Derivatives
  • 7.3. Peptide Hormones
  • 7.4. Steroid Hormones

8. Human Growth Hormone Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Human Growth Hormone Market, by Application

  • 9.1. Introduction
  • 9.2. Growth Hormone Deficiency
  • 9.3. Prader-Willi Syndrome
  • 9.4. Turner Syndrome

10. Americas Human Growth Hormone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Growth Hormone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Growth Hormone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HUMAN GROWTH HORMONE MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN GROWTH HORMONE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 5. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 7. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. HUMAN GROWTH HORMONE MARKET DYNAMICS
  • FIGURE 10. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HUMAN GROWTH HORMONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 5. HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HUMAN GROWTH HORMONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HUMAN GROWTH HORMONE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. HUMAN GROWTH HORMONE MARKET SIZE, BY AMINO ACID DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HUMAN GROWTH HORMONE MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HUMAN GROWTH HORMONE MARKET SIZE, BY STEROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 14. HUMAN GROWTH HORMONE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HUMAN GROWTH HORMONE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HUMAN GROWTH HORMONE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. HUMAN GROWTH HORMONE MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. HUMAN GROWTH HORMONE MARKET SIZE, BY PRADER-WILLI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HUMAN GROWTH HORMONE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. HUMAN GROWTH HORMONE MARKET LICENSE & PRICING